Abstract |
Dissociated agonists of the glucocorticoid receptor (DAGRs) show similar antiinflammatory effects but improved tolerability compared with standard glucocorticoid receptor (GR) agonists. The prodrug fosdagrocorat (PF-04171327), with active DAGR metabolite PF-00251802 (Metabolite-1), is postulated to show superior efficacy over placebo and prednisone in patients with moderate to severe rheumatoid arthritis (RA). We investigated the population pharmacokinetics of active Metabolite-1 and its active metabolite PF-04015475 (Metabolite-2) in patients with moderate to severe RA enrolled in a 12-week, phase II, randomized, double-blind study (NCT01393639). A simultaneous fit of a two-compartment model for Metabolite-1 and a one-compartment model for Metabolite-2 provided an adequate fit to the data. Significant covariates included weight, with an additional female effect on clearance of Metabolite-1 (∼26%) and Metabolite-2 (∼33%) compared with males. Age influenced clearance of Metabolite-1. In combination, age, weight, and sex predicted >twofold differences in area under the concentration-time curve of Metabolite-1 at the extremes.
|
Authors | Barry Weatherley, Lynn McFadyen, Brinda Tammara |
Journal | Clinical and translational science
(Clin Transl Sci)
Vol. 11
Issue 1
Pg. 54-62
(01 2018)
ISSN: 1752-8062 [Electronic] United States |
PMID | 29106053
(Publication Type: Clinical Trial, Phase II, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. |
Chemical References |
- Glucocorticoids
- Organophosphates
- Phenanthrenes
- Prodrugs
- Receptors, Glucocorticoid
- fosdagrocorat
- Prednisone
|
Topics |
- Administration, Oral
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Area Under Curve
- Arthritis, Rheumatoid
(diagnosis, drug therapy)
- Biological Variation, Population
- Body Weight
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Glucocorticoids
(pharmacokinetics, therapeutic use)
- Humans
- Male
- Middle Aged
- Models, Biological
- Organophosphates
(administration & dosage, adverse effects, pharmacokinetics)
- Phenanthrenes
(administration & dosage, adverse effects, pharmacokinetics)
- Prednisone
(pharmacokinetics, therapeutic use)
- Prodrugs
(administration & dosage, adverse effects, pharmacokinetics)
- Receptors, Glucocorticoid
(agonists)
- Severity of Illness Index
- Sex Factors
- Young Adult
|